跳至主要内容
临床试验/NCT06326970
NCT06326970尚未招募不适用

SPECT Fibroblast Activation Protein Imaging in Patients With Cardiac Disease

Henan Institute of Cardiovascular Epidemiology0 个研究点目标入组 50 人开始时间: 2024年3月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
主要终点
positive uptake

研究概览

简要总结

This observational study aims to learn about the preliminary exploration of 99mTc-FAPI imaging in heart diseases and its potential application.

Participant involves patients with myocarditis, pulmonary hypertension, arrhythmia, myocardial infarction, dilated cardiomyopathy, and cardiac tumors, health conditions may also studied as control.

The main questions it aims to answer are 1, radionuclide 99mTc labeled fibroblast-activated protein inhibitors (99mTc-FAPI) imaging in the use of cardiac diseases and its limitations. 2, the performance in subjects with different control of hypertension to evaluate myocardial injury and fibrosis for providing a molecular biological basis for the study of diseases and mechanisms.

Participants will undergo 99mTc-FAPI imaging by Single-photon emission computed tomography (SPECT) and record their cardiac disease characterization and treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis or suspected of cardiac injury
  • Must be able to receive PET/CT scan

排除标准

  • Pregnant women
  • Severe claustrophobia

结局指标

主要结局

positive uptake

时间窗: 3 months

99mTc-FAPI accumulation on the heart, measure the standardized uptake values (SUV)

次要结局

未报告次要终点

研究者

发起方
Henan Institute of Cardiovascular Epidemiology
申办方类型
Other
责任方
Sponsor

相似试验